Somatic DNA Copy-Number Alterations Detection for Esophageal Adenocarcinoma Using Digital Polymerase Chain Reaction

Author(s):  
Katherine T. W. Lee ◽  
Vinod Gopalan ◽  
Alfred K. Lam
2020 ◽  
Vol 2020 ◽  
pp. 1-8
Author(s):  
Chen Chen ◽  
Jia Chen ◽  
Yan Zhang ◽  
Yongbo Li ◽  
Zan Wang ◽  
...  

A single-copy specific primer was designed based on beef and duck samples and through drop digital polymerase chain reaction (ddPCR) for the quantitative analysis. Results revealed that the primers had no specific amplification with sheep, chicken, pork, or other species. Both the relationships between meat weight and DNA weight and between DNA weight and DNA copy number (C) were nearly linear within the dynamic range. To calculate the original meat weight from the DNA copy number, the DNA weight was used as the intermediate value to establish the following formulae: Mbeef = 0.058C − 1.86; Mduck = 0.0268C − 7.78. To achieve a good quantitative analysis, all species used in the experiment were made of lean meat. The accuracy of the method was verified by artificial adulteration of different proportions. Testing of the commercial samples indicated that adulteration is present in the market. The established digital PCR method provided an effective tool for monitoring the adulterated meat products and reducing the adulteration in the market.


2011 ◽  
Vol 84 (2) ◽  
pp. 1003-1011 ◽  
Author(s):  
Leonardo B. Pinheiro ◽  
Victoria A. Coleman ◽  
Christopher M. Hindson ◽  
Jan Herrmann ◽  
Benjamin J. Hindson ◽  
...  

BMC Genomics ◽  
2007 ◽  
Vol 8 (1) ◽  
pp. 206 ◽  
Author(s):  
Kyoko Iwao-Koizumi ◽  
Kazunori Maekawa ◽  
Yohko Nakamura ◽  
Sakae Saito ◽  
Shoko Kawamoto ◽  
...  

2021 ◽  
pp. 910-920
Author(s):  
P. Mickey Williams ◽  
Thomas Forbes ◽  
Steven P. Lund ◽  
Kenneth D. Cole ◽  
Hua-Jun He ◽  
...  

PURPOSE We report the results from a Foundation for the National Institutes of Health Biomarkers Consortium project to address the absence of well-validated quality control materials (QCMs) for circulating tumor DNA (ctDNA) testing. This absence is considered a cause of variance and inconsistencies in translating ctDNA results into clinical actions. METHODS In this phase I study, QCMs with 14 clinically relevant mutations representing single nucleotide variants, insertions or deletions (indels), translocations, and copy number variants were sourced from three commercial manufacturers with variant allele frequencies (VAFs) of 5%, 2.5%, 1%, 0.1%, and 0%. Four laboratories tested samples in quadruplicate using two allele-specific droplet digital polymerase chain reaction and three (amplicon and hybrid capture) next-generation sequencing (NGS) panels. RESULTS The two droplet digital polymerase chain reaction assays reported VAF values very close to the manufacturers’ claimed concentrations for all QCMs. NGS assays reported most single nucleotide variants and indels, but not translocations, close to the expected VAF values. Notably, two NGS assays reported lower VAF than expected for all translocations in all QCM mixtures, possibly related to technical challenges detecting these variants. The ability to call ERBB2 copy number amplifications varied across assays. All three QCMs provided valuable insight into assay precision. Each assay across all variant types demonstrated dropouts at 0.1%, suggesting that the QCM can serve for testing of an assay’s limit of detection with confidence claims for specific variants. CONCLUSION These results support the utility of the QCM in testing ctDNA assay analytical performance. However, unique designs and manufacturing methods for the QCM, and variations in a laboratory’s testing configuration, may require testing of multiple QCMs to find the best reagents for accurate result interpretation.


Sign in / Sign up

Export Citation Format

Share Document